Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study. (Q46010882)
Jump to navigation
Jump to search
scientific article published on 26 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study. |
scientific article published on 26 July 2015 |
Statements
1 reference
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study. (English)
1 reference
Hagop M Kantarjian
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Jorge E Cortes
1 reference
Jerald Radich
1 reference
Vivian G Oehler
1 reference
Catriona Jamieson
1 reference
Rachel Courtney
1 reference
M Naveed Shaik
1 reference
Xiaoxi Zhang
1 reference
Ashleigh O'Connell
1 reference
Karen R McLachlan
1 reference
Xianxian Zheng
1 reference
Wendy J Levin
1 reference
26 July 2015
1 reference
1 reference
2
1 reference
e339-46
1 reference
8
1 reference
Identifiers
1 reference
1 reference